Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Nature Reviews. Neurology
|
January 14, 2021
Aducanumab and the FDA - where are we now?
Howard Fillit, Allan Green
Current Alzheimer Research
|
February 14, 2006
Neurogenesis as a therapeutic strategy for cognitive aging and Alzheimer's disease
Gunnar Gouras, Howard Fillit
The American Journal of Cardiology
|
April 18, 2006
Cardiovascular disease risk factors and cognitive impairment
David T Nash, Howard Fillit
Journal of the American Geriatrics Society
|
February 12, 2009
The frailty identity crisis
Howard Fillit, Robert N Butler
The American Journal of Geriatric Pharmacotherapy
|
September 1, 2005
Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study
Shaoli Lu, Jerrold Hill, Howard Fillit
The Journal of Prevention of Alzheimer'S Disease
|
October 27, 2025
Add-on combination therapy with monoclonal antibodies: Implications for drug development
Jeffrey Cummings, Aaron H Burstein, Howard Fillit
Family Medicine
|
July 30, 2002
Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy
Howard Fillit, Jerrold W Hill, Robert Futterman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 31, 2009
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke
Howard Fillit, David T Nash, Diana Shineman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 23, 2018
Accelerating Alzheimer's disease drug innovations from the research pipeline to patients
Dana P Goldman, Howard Fillit, Peter Neumann
The Journal of Prevention of Alzheimer'S Disease
|
October 27, 2025
Alzheimer Combination Therapies: Overview and Scenarios
Jeffrey L Cummings, Aaron H Burstein, Howard Fillit
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Nature Reviews. Neurology
|
January 14, 2021
Aducanumab and the FDA - where are we now?
Howard Fillit, Allan Green
Current Alzheimer Research
|
February 14, 2006
Neurogenesis as a therapeutic strategy for cognitive aging and Alzheimer's disease
Gunnar Gouras, Howard Fillit
The American Journal of Cardiology
|
April 18, 2006
Cardiovascular disease risk factors and cognitive impairment
David T Nash, Howard Fillit
Journal of the American Geriatrics Society
|
February 12, 2009
The frailty identity crisis
Howard Fillit, Robert N Butler
The American Journal of Geriatric Pharmacotherapy
|
September 1, 2005
Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study
Shaoli Lu, Jerrold Hill, Howard Fillit
The Journal of Prevention of Alzheimer'S Disease
|
October 27, 2025
Add-on combination therapy with monoclonal antibodies: Implications for drug development
Jeffrey Cummings, Aaron H Burstein, Howard Fillit
Family Medicine
|
July 30, 2002
Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy
Howard Fillit, Jerrold W Hill, Robert Futterman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 31, 2009
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke
Howard Fillit, David T Nash, Diana Shineman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 23, 2018
Accelerating Alzheimer's disease drug innovations from the research pipeline to patients
Dana P Goldman, Howard Fillit, Peter Neumann
The Journal of Prevention of Alzheimer'S Disease
|
October 27, 2025
Alzheimer Combination Therapies: Overview and Scenarios
Jeffrey L Cummings, Aaron H Burstein, Howard Fillit
Page
of 8